HMGA1-pseudogene expression is induced in human pituitary tumors

Cell Cycle

Volumn 14, Issue 9, 2015, Pages 1471-1475

  Esposito, Francesco ^a   De Martino, Marco ^a   D’Angelo, Daniela ^a   Mussnich, Paula ^a   Raverot, Gerald ^b,c   Jaffrain Rea, Marie Lise ^d,e   Fraggetta, Filippo ^f   Trouillas, Jacqueline ^b,c   Fusco, Alfredo ^a,g  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b LYON NEUROSCIENCE RESEARCH CENTER   (France)

^c HOSPICES CIVILS DE LYON   (France)

^d UNIVERSITY OF L'AQUILA   (Italy)

^e IRCCS NEUROMED   (Italy)

^f CANNIZZARO HOSPITAL   (Italy)

^g INSTITUTO NACIONAL DE CÂNCER   (Brazil)

Author keywords

ceRNA; HMGA1; HMGA1P6; HMGA1P7; miRNA

Indexed keywords

GROWTH HORMONE; HIGH MOBILITY GROUP A PROTEIN; MESSENGER RNA; MICRORNA; TUMOR MARKER;

ARTICLE; CARCINOGENESIS; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; GENE EXPRESSION; GENE REPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOPHYSIS TUMOR; PITUITARY TUMOR CELL LINE; PSEUDOGENE; UPREGULATION; ADENOMA; ANIMAL; CELL MOTION; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GENETICS; METABOLISM; MOUSE; PATHOLOGY; TIME FACTOR; TUMOR CELL LINE;

ADENOMA; ANIMALS; BIOMARKERS, TUMOR; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HMGA PROTEINS; HUMANS; MICE; PITUITARY NEOPLASMS; PSEUDOGENES; RNA, MESSENGER; TIME FACTORS; TRANSFECTION; UP-REGULATION;

EID: 84948742108     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.1080/15384101.2015.1021520     Document Type: Article

References (16)

1. Fusco A, Fedele M. Roles of the HMGA proteins in cancer. Nat Rev Cancer 2007; 7: 899-910; PMID:18004397; http://dx.doi.org/10.1038/nrc2271
2. Pegoraro S, Ros G, Piazza S, Sommaggio R, Ciani Y, Rosato A, Sgarra R, Del Sal G, Manfioletti G. HMGA1 promotes metastatic processes in basal-like breast cancer regulating EMT and stemness. Oncotarget 2013; 4: 1293-308; PMID:23945276
3. Puca F, Colamaio M, Federico A, Gemei M, Tosti N, Bastos AU, Del Vecchio L, Pece S, Battista S, Fusco A. HMGA1 silencing restores normal stem cell characteristics in colon cancer stem cells by increasing p53 levels. Oncotarget 2014; 5: 3234-45; PMID:24833610
4. Pierantoni GM, Finelli P, Valtorta E, Giardino D, Rodeschini O, Esposito F, Losa M, Fusco A, Larizza L. High-mobility group A2 gene expression is frequently induced in non-functioning pituitary adenomas (NFPAs), even in the absence of chromosome 12 polysomy. Endocr Relat Cancer 2005; 12: 867-74; PMID:16322327; http://dx.doi.org/ 10.1677/erc.1.01049
5. Fedele M, Pierantoni GM, Visone R, Fusco A. Critical role of the HMGA2 gene in pituitary adenomas. Cell Cycle 2006; 5: 2045-8; PMID:16969098; http://dx. doi.org/10.4161/cc.5.18.3211
6. Fedele M, Visone R, De Martino I, Troncone G, Palmieri D, Battista S, Ciarmiello A, Pallante P, Arra C, Melillo RM, et al. HMGA2 induces pituitary tumorigenesis by enhancing E2F1 activity. Cancer Cell 2006; 9: 459-71; PMID:16766265; http://dx.doi.org/ 10.1016/j.ccr.2006.04.024
7. Fedele M, Fusco A. Role of the high mobility group A proteins in the regulation of pituitary cell cycle. J Mol Endocrinol 2010; 44: 309-18; PMID:20219853; http://dx.doi.org/10.1677/JME-09-0178
8. Palmieri D, Valentino T, De Martino I, Esposito F, Cappabianca P, Wierinckx A, Vitiello M, Lombardi G, Colao A, Trouillas J, et al. PIT1 upregulation by HMGA proteins has a role in pituitary tumorigenesis. Endocr Relat Cancer 2012; 19: 123-35; PMID:22199144; http://dx.doi.org/10.1530/ERC-11-0135
9. Palmieri D, D'Angelo D, Valentino T, De Martino I, Ferraro A, Wierinckx A, Fedele M, Trouillas J, Fusco A. Downregulation of HMGA-targeting microRNAs has a critical role in human pituitary tumorigenesis. Oncogene 2012; 31: 3857-65; PMID:22139073; http://dx.doi.org/10.1038/onc.2011.557
10. D'Angelo D, Palmieri D, Mussnich P, Roche M, Wierinckx A, Raverot G, Fedele M, Croce CM, Trouillas J, Fusco A. Altered microRNA expression profile in human pituitary GH adenomas: down-regulation of miRNA targeting HMGA1, HMGA2, and E2F1. J Clin Endocrinol Metab 2012; 97: E1128-38; PMID:22564666; http://dx.doi.org/10.1210/jc.2011-3482
11. Leone V, Langella C, D'Angelo D,Mussnich P,Wierinckx A, Terracciano L, Raverot G, Lachuer J, Rotondi S, Jaffrain-Rea ML, et al. Mir-23b and miR-130b expression is downregulated in pituitary adenomas.Mol Cell Endocrinol 2014; 390: 1-7; PMID:24681352; http://dx.doi.org/ 10.1016/j.mce.2014.03.002
12. Esposito F, De Martino M, Petti MG, Forzati F, Tornincasa M, Federico A, Arra C, Pierantoni GM, Fusco A. HMGA1 pseudogenes as candidate proto-oncogenic competitive endogenous RNAs. Oncotarget 2014; 5: 8341-54; PMID:25268743
13. Esposito F, De Martino M, Forzati F, Fusco A. HMGA1-pseudogene overexpression contributes to cancer progression. Cell Cycle 2014; 13: 3636-9; PMID:25483074; http://dx.doi.org/10.4161/ 15384101.2014.974440
14. Martinez Hoyos J, Ferraro A, Sacchetti S, Keller S,DeMartino I, Borbone E, Pallante P, Fedele M, Montanaro D, Esposito F, et al.HAND1 gene expression is negatively regulated by theHighMobilityGroup A1 proteins and is drastically reduced in human thyroid carcinomas. Oncogene 2009; 28: 876-85; PMID:19060921; http://dx.doi.org/ 10.1038/onc.2008.438
15. Piscuoglio S, Zlobec I, Pallante P, Sepe R, Esposito F, Zimmermann A, Diamantis I, Terracciano L, Fusco A, Karamitopoulou E. HMGA1 and HMGA2 protein expression correlates with advanced tumour grade and lymph node metastasis in pancreatic adenocarcinoma. Histopathology 2012; 60: 397-404; PMID:22276603; http://dx.doi.org/10.1111/j.1365-2559.2011.04121.x
16. Borbone E, Troncone G, Ferraro A, Jasencakova Z, Stojic L, Esposito F, Horning N, Fusco A, Orlando V. Enhancer of zeste homolog 2 overexpression has a role in the development of anaplastic thyroid carcinomas. J Clin Endocrinol Metab 2011; 96: 1029-38; PMID:21289264; http://dx.doi.org/10.1210/jc.2010-1784